Teleflex Incorporated (TFX): Price and Financial Metrics


Teleflex Incorporated (TFX)

Today's Latest Price: $375.23 USD

7.57 (-1.98%)

Updated Jan 27 2:58pm

Add TFX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 188 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

TFX Stock Summary

  • With a one year PEG ratio of 826.83, Teleflex Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 95.19% of US stocks.
  • Teleflex Inc's stock had its IPO on February 18, 1988, making it an older stock than 89.29% of US equities in our set.
  • In terms of volatility of its share price, TFX is more volatile than merely 4.73% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Teleflex Inc, a group of peers worth examining would be GNRC, XYL, FTV, PKI, and STE.
  • TFX's SEC filings can be seen here. And to visit Teleflex Inc's official web site, go to www.teleflex.com.

TFX Stock Price Chart Interactive Chart >

Price chart for TFX

TFX Price/Volume Stats

Current price $375.23 52-week high $414.72
Prev. close $382.80 52-week low $221.27
Day low $371.83 Volume 105,060
Day high $379.41 Avg. volume 222,484
50-day MA $389.18 Dividend yield 0.36%
200-day MA $366.55 Market Cap 17.47B

Teleflex Incorporated (TFX) Company Bio


Teleflex Inc. designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company was founded in 1943 and is based in Wayne, Pennsylvania.

TFX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$375.23$64.71 -83%

We started the process of determining a valid price forecast for Teleflex Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Teleflex Inc ranked in the 17th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Teleflex Inc, consider:

  • The company has produced more trailing twelve month cash flow than 61.74% of its sector Healthcare.
  • 89% of the company's capital comes from equity, which is greater than 70.81% of stocks in our cash flow based forecasting set.
  • TFX's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 32.07% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-83%
1%-83%
2%-83%
3%-83%
4%-83%
5%-83%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as TFX, try AMPH, LGND, CNMD, LMNX, and ZBH.


TFX Latest News Stream


Event/Time News Detail
Loading, please wait...

TFX Latest Social Stream


Loading social stream, please wait...

View Full TFX Social Stream

Latest TFX News From Around the Web

Below are the latest news stories about Teleflex Inc that investors may wish to consider to help them evaluate TFX as an investment opportunity.

Central Venous Catheter Market Major Players - AngioDynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and Theragenics Corporation

Global Central Venous Catheter Market: The report provides a valuable source of insightful data for business strategists and competitive analysis of Central Venous Catheter Market. The study covers important knowledge that makes the analysis document a handy resource for managers,

OpenPR | January 20, 2021

Published Data Demonstrate Sexual Function Improvement and Preservation with the Minimally Invasive UroLift® System Compared to Medications Prescribed for Benign Prostatic Hyperplasia

WAYNE, Pa., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that new data published in the peer-reviewed journal, European Urology Focus, found that men treated with the Prostatic Urethral Lift (PUL) procedure (using the UroLift® System) showed preservation and some improvement of sexual function compared to men being treated with medication for benign prostatic hyperplasia (BPH). The comparative analysis “Prostatic Urethral Lift vs. Medical Therapy: Examining the Impact on Sexual Function in Men with BPH,” is the first study to longitudinally compare sexual function outcomes between major PUL studies1-4 and data from the Medical Therapy of Prostatic Symptoms (MTOPS) trial. Treatment-related changes in sexual function were reported by validated patien...

Yahoo | January 20, 2021

Cardiac Catheters Market to Witness Huge Growth by 2026| Boston Scientific, Cordis(Cardinal health), Abbott, BBRAUN, Medtronic, Terumo, Teleflex, C. R. Bard, Edwards, Cook, Merit Medical, Biotronik, St.Jude Medical, BALT, Osypka AG, Japan Lifeline, ACT, L

ReportsnReports.com the exclusive leading provider of market research reports published research report on “Global Cardiac Catheters Market Insights, Forecast to 2026”. The Global Cardiac Catheters Market Report 2020 is a professional and in-depth study on the current state of the Cardiac

OpenPR | January 16, 2021

Global Central Venous Catheters Market Analysis and Forecast to 2030 Featuring Teleflex, CR Bard, Edwards Lifesciences, Vygon, B. Braun Melsungen, Smiths Medical & Kimal

DUBLIN, Jan. 8, 2021 /PRNewswire/ -- The "Central Venous Catheters (Drug Delivery Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering. Central Venous Catheters (Drug Delivery Devices) - Global Market…

PR Newswire | January 8, 2021

Medical Tubing Market 2020 Will Grow at Huge CAGR of 9.30% by 2027 With Global Players - Zeus Industrial Products, Inc, Saint-Gobain, Teleflex Incorporated, Optinova AB

Market Overview Medical tubing market is expected to be growing at a growth rate of 9.30% in the forecast period of 2020 to 2027. Medical tubing market report analyses the growth, which is currently being growing due to the rising demand

OpenPR | January 5, 2021

Read More 'TFX' Stories Here

TFX Price Returns

1-mo -7.71%
3-mo 14.98%
6-mo 0.76%
1-year -0.97%
3-year 33.65%
5-year 184.60%
YTD -8.83%
2020 9.75%
2019 46.26%
2018 4.45%
2017 55.41%
2016 23.66%

TFX Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full TFX Dividend History

Continue Researching TFX

Want to see what other sources are saying about Teleflex Inc's financials and stock price? Try the links below:

Teleflex Inc (TFX) Stock Price | Nasdaq
Teleflex Inc (TFX) Stock Quote, History and News - Yahoo Finance
Teleflex Inc (TFX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8867 seconds.